Literature DB >> 22081234

Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis.

Agnieszka Prytuła1, David Wells, Timothy McLean, Filipa Balona, Ambrose Gullett, Craig Knott, Michelle Cantwell, Kimberly Hassen, Sarah Ledermann, Lesley Rees, Rukshana Shroff.   

Abstract

BACKGROUND: Vitamin D deficiency is widely prevalent in chronic kidney disease [CKD] patients. The aim of our study was to determine whether losses of vitamin D binding protein [VDBP] in urine and dialysate contribute to circulating 25-hydroxyvitamin D [25OHD] levels in chronic peritoneal dialysis [PD] patients.
METHODS: Dialysate, serum, and urine VDBP levels were measured in 16 children on PD and compared with serum and urine VDBP in ten CKD4-5 patients. Serum VDBP levels were correlated with total circulating 25OHD and peritoneal VDBP losses.
RESULTS: The mean age of the study population was 9.4 ± 3.8 years and the median time on dialysis 7.5 (1-18) months. In CKD4-5 patients, urinary VDBP losses were >300-fold higher than seen in age-matched healthy children and correlated with urinary albumin loss (p = 0.0008). There was a significant correlation between serum VDBP and total dialysate and urine losses of VDBP (p = 0.03, r = -0.53). Dialysate VDBP losses correlate with dialysate albumin loss (p = 0.01). VDBP losses in the long daytime dwell were higher than in the overnight drain (p = 0.04). Serum VDBP levels were lower in children with a longer dialysis vintage (p = 0.0004, r = -0.77). In PD patients, the mean total loss of VDBP in dialysate and urine was 1.91 ± 1.6 μmol/day, equivalent to ~7% of the total circulating level of VDBP in healthy controls. There was no correlation between 25(OH)D and VDBP.
CONCLUSIONS: Peritoneal VDBP losses mirror both dialysate and urinary albumin losses, and are associated with a longer dialysis vintage but do not contribute to vitamin D deficiency in children on PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081234     DOI: 10.1007/s00467-011-2045-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 2.  Pharmacokinetics of vitamin D toxicity.

Authors:  Glenville Jones
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

3.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

4.  Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.

Authors:  Y Aloni; S Shany; C Chaimovitz
Journal:  Miner Electrolyte Metab       Date:  1983 Mar-Apr

5.  Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.

Authors:  J G Haddad; J Walgate
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

6.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

Review 7.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.

Authors:  Marijn Speeckaert; Guangming Huang; Joris R Delanghe; Youri E C Taes
Journal:  Clin Chim Acta       Date:  2006-05-12       Impact factor: 3.786

8.  Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.

Authors:  Mieczyslaw Litwin; Elke Wühl; Claudia Jourdan; Anna Niemirska; Jens P Schenk; Katarzyna Jobs; Ryszard Grenda; Zbigniew T Wawer; Pawel Rajszys; Otto Mehls; Franz Schaefer
Journal:  Nephrol Dial Transplant       Date:  2008-03-14       Impact factor: 5.992

9.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.

Authors:  Rukshana C Shroff; Rosamund McNair; Nichola Figg; Jeremy N Skepper; Leon Schurgers; Ashmeet Gupta; Melanie Hiorns; Ann E Donald; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  Circulation       Date:  2008-10-06       Impact factor: 29.690

View more
  12 in total

1.  Vitamin D status of children receiving chronic dialysis.

Authors:  Basema I Dibas; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

2.  Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis.

Authors:  Rukshana Shroff; Mandy Wan; Evi V Nagler; Sevcan Bakkaloglu; Dagmar-C Fischer; Nicholas Bishop; Mario Cozzolino; Justine Bacchetta; Alberto Edefonti; Constantinos J Stefanidis; Johan Vande Walle; Dieter Haffner; Günter Klaus; Claus Peter Schmitt
Journal:  Nephrol Dial Transplant       Date:  2017-07-01       Impact factor: 5.992

3.  Vitamin D status in children with chronic kidney disease.

Authors:  Deborah R Stein; Henry A Feldman; Catherine M Gordon
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

4.  Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.

Authors:  Rukshana Shroff; Helen Aitkenhead; Nikola Costa; Antonella Trivelli; Mieczyslaw Litwin; Stefano Picca; Ali Anarat; Peter Sallay; Fatih Ozaltin; Aleksandra Zurowska; Augustina Jankauskiene; Giovanni Montini; Marina Charbit; Franz Schaefer; Elke Wühl
Journal:  J Am Soc Nephrol       Date:  2015-06-11       Impact factor: 10.121

5.  Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.

Authors:  Hee Yeon Cho; Hye Sun Hyun; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong
Journal:  Perit Dial Int       Date:  2012-12-03       Impact factor: 1.756

Review 6.  Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review.

Authors:  Roberto Russo; Marinella Ruospo; Mario Cozzolino; Luca De Nicola; Andrea Icardi; Ernesto Paoletti; Sandro Mazzaferro
Journal:  J Nephrol       Date:  2014-07-11       Impact factor: 3.902

7.  Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.

Authors:  Michelle R Denburg; Heidi J Kalkwarf; Ian H de Boer; Martin Hewison; Justine Shults; Babette S Zemel; David Stokes; Debbie Foerster; Benjamin Laskin; Anthony Ramirez; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2013-06-02       Impact factor: 3.714

Review 8.  Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions.

Authors:  Pegah Yousefzadeh; Sue A Shapses; Xiangbing Wang
Journal:  Int J Endocrinol       Date:  2014-04-28       Impact factor: 3.257

9.  A lack of association between vitamin D-binding protein and 25-hydroxyvitamin D concentrations in pediatric type 1 diabetes without microalbuminuria.

Authors:  Hwa Young Kim; Young Ah Lee; Hae Woon Jung; Min Jeoung Gu; Ji Young Kim; Gyung Min Lee; Jieun Lee; Ju Young Yoon; Sei Won Yang; Choong Ho Shin
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

10.  Proteomics investigation of the changes in serum proteins after high- and low-flux hemodialysis.

Authors:  Shuai Han; Kaiguang Yang; Hong Zhu; Jianhui Liu; Lihua Zhang; Jiuyang Zhao
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.